• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用真实世界数据和真实世界证据时要谨慎。

Proceed with Caution When Using Real World Data and Real World Evidence.

机构信息

Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Department of Endocrinology and Metabolism, College of Medicine, The Catholic University of Korea, Seoul, Korea.

出版信息

J Korean Med Sci. 2019 Jan 16;34(4):e28. doi: 10.3346/jkms.2019.34.e28. eCollection 2019 Jan 28.

DOI:10.3346/jkms.2019.34.e28
PMID:30686950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6345637/
Abstract

Clinical studies can be conducted to gather real world evidence (RWE) not available from randomized controlled trials, providing new information and knowledge. Although the concept of RWE emerged relatively recently, numerous clinical studies are utilizing it. However, many researchers are engaging in trial and error that may not overcome the various biases that occur in electronic medical record (EMR)-based RWE studies. While RWE can reflect the real world, there are still limitations to its acceptance. There are many hurdles in using RWE and solutions must be explored. Results based on RWE may be overestimated and it can be difficult to derive good quality results. This paper discusses data quality management, direct chart review, sample size, study design, and the interpretation of EMR-based RWE. More specifically, this paper shares the experience of the various hurdles that occur when conducting RWE studies and discusses the easy-to-false errors. RWE is still in the developmental stage and numerous aspects of RWE use remain unclear. Nonetheless, despite its many limitations, increasing use of RWE is still anticipated. This will require continued experience and effort in using RWE, as well as upgrading RWE research through the accumulation of information on such experiences and efforts.

摘要

临床研究可以用来收集随机对照试验中无法获得的真实世界证据(RWE),从而提供新的信息和知识。尽管 RWE 的概念是最近才出现的,但许多临床研究都在使用它。然而,许多研究人员都在进行试错,这可能无法克服电子病历(EMR)中 RWE 研究中存在的各种偏倚。虽然 RWE 可以反映现实世界,但它的接受程度仍然存在局限性。在使用 RWE 方面存在许多障碍,必须探索解决方案。基于 RWE 的结果可能会被高估,并且很难得出高质量的结果。本文讨论了数据质量管理、直接图表审查、样本量、研究设计以及基于 EMR 的 RWE 的解释。更具体地说,本文分享了在进行 RWE 研究时遇到的各种障碍的经验,并讨论了容易出现的错误。RWE 仍处于发展阶段,RWE 使用的许多方面仍不清楚。尽管存在许多局限性,但预计 RWE 的使用仍将增加。这将需要在使用 RWE 方面不断积累经验和努力,以及通过积累有关这些经验和努力的信息来提升 RWE 研究。

相似文献

1
Proceed with Caution When Using Real World Data and Real World Evidence.使用真实世界数据和真实世界证据时要谨慎。
J Korean Med Sci. 2019 Jan 16;34(4):e28. doi: 10.3346/jkms.2019.34.e28. eCollection 2019 Jan 28.
2
Real-world Evidence versus Randomized Controlled Trial: Clinical Research Based on Electronic Medical Records.真实世界证据与随机对照试验:基于电子病历的临床研究。
J Korean Med Sci. 2018 Jun 26;33(34):e213. doi: 10.3346/jkms.2018.33.e213. eCollection 2018 Aug 20.
3
Translational hurdles with cannabis medicines.大麻药物转化的障碍。
Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1325-1330. doi: 10.1002/pds.4999. Epub 2020 Apr 12.
4
[Real-world evidence : Benefits and limitations in multiple sclerosis research].[真实世界证据:多发性硬化症研究中的益处与局限性]
Nervenarzt. 2017 Oct;88(10):1153-1158. doi: 10.1007/s00115-017-0387-y.
5
The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.真实世界证据在慢性髓性白血病临床研究未来中的应用。
Clin Ther. 2019 Feb;41(2):336-349. doi: 10.1016/j.clinthera.2018.12.013. Epub 2019 Jan 30.
6
Meta-analyses using real-world data to generate clinical and epidemiological evidence: a systematic literature review of existing recommendations.使用真实世界数据进行荟萃分析以生成临床和流行病学证据:现有建议的系统文献综述。
Curr Med Res Opin. 2018 Dec;34(12):2125-2130. doi: 10.1080/03007995.2018.1524751. Epub 2018 Sep 25.
7
Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?真实世界证据(RWE)——是颠覆性创新还是医学证据生成的悄然演进?
F1000Res. 2018 Jan 25;7:111. doi: 10.12688/f1000research.13585.2. eCollection 2018.
8
Toward a better understanding about real-world evidence.迈向对真实世界证据更好的理解。
Eur J Hosp Pharm. 2022 Jan;29(1):8-11. doi: 10.1136/ejhpharm-2021-003081. Epub 2021 Dec 2.
9
The Expanding Role of Real-World Evidence Trials in Health Care Decision Making.真实世界证据试验在医疗保健决策中的作用不断扩大。
J Diabetes Sci Technol. 2020 Jan;14(1):174-179. doi: 10.1177/1932296819832653. Epub 2019 Mar 6.
10
Use of real-world evidence for oncology clinical decision making in emerging economies.新兴经济体中使用真实世界证据进行肿瘤学临床决策。
Future Oncol. 2021 Aug;17(22):2951-2960. doi: 10.2217/fon-2021-0425. Epub 2021 May 28.

引用本文的文献

1
Perioperative Coronavirus Disease 2019 Infection and Its Impact on Postoperative Outcomes: Pulmonary Complications and Mortality Based on Korean National Health Insurance Data.2019冠状病毒病围手术期感染及其对术后结局的影响:基于韩国国民健康保险数据的肺部并发症和死亡率
J Pers Med. 2025 Apr 17;15(4):157. doi: 10.3390/jpm15040157.
2
Importance of Health Economics and Outcomes Research in the Product Lifecycle.健康经济学与结果研究在产品生命周期中的重要性。
Pharmaceut Med. 2025 Apr 14. doi: 10.1007/s40290-025-00564-z.
3
Use of real-world evidence in the Medicare Drug Price Negotiation Program: A checklist for the Centers for Medicare and Medicaid Services and manufacturers.在医疗保险药品价格谈判计划中使用真实世界证据:给医疗保险和医疗补助服务中心及制造商的一份清单。
Health Aff Sch. 2025 Mar 21;3(3):qxaf030. doi: 10.1093/haschl/qxaf030. eCollection 2025 Mar.
4
Prevalence of Mortality and Vascular Complications in Older Patients with Diabetes in Korea.韩国老年糖尿病患者的死亡率和血管并发症患病率
Endocrinol Metab (Seoul). 2025 Jun;40(3):448-458. doi: 10.3803/EnM.2024.2173. Epub 2025 Feb 18.
5
Antibiotic Use and Survival in Patients With Late-Stage NSCLC Treated With Chemoimmunotherapy.化疗免疫疗法治疗晚期非小细胞肺癌患者的抗生素使用与生存情况
JTO Clin Res Rep. 2024 Jul 31;5(12):100710. doi: 10.1016/j.jtocrr.2024.100710. eCollection 2024 Dec.
6
Effects of statin use on serum creatinine phosphokinase levels in normal thyroid function.他汀类药物使用对甲状腺功能正常者血清肌酐磷酸激酶水平的影响。
Korean J Intern Med. 2024 Jul;39(4):650-658. doi: 10.3904/kjim.2024.085. Epub 2024 Jun 24.
7
Utilizing electronic medical records alert to improve documentation of neonatal acute kidney injury.利用电子病历警报改善新生儿急性肾损伤的文档记录。
Pediatr Nephrol. 2024 Aug;39(8):2505-2514. doi: 10.1007/s00467-024-06352-2. Epub 2024 Mar 22.
8
Dark Data in Real-World Evidence: Challenges, Implications, and the Imperative of Data Literacy in Medical Research.真实世界证据中的暗数据:医学研究中的挑战、影响及数据素养的必要性
J Korean Med Sci. 2024 Mar 11;39(9):e92. doi: 10.3346/jkms.2024.39.e92.
9
Biases in Electronic Health Records Data for Generating Real-World Evidence: An Overview.用于生成真实世界证据的电子健康记录数据中的偏差:概述
J Healthc Inform Res. 2023 Nov 14;8(1):121-139. doi: 10.1007/s41666-023-00153-2. eCollection 2024 Mar.
10
Comorbidity Patterns and Management in Inpatients with Endocrine Diseases by Age Groups in South Korea: Nationwide Data.韩国按年龄组划分的内分泌疾病住院患者的共病模式与管理:全国数据
J Pers Med. 2023 Dec 28;14(1):42. doi: 10.3390/jpm14010042.

本文引用的文献

1
Real-world Evidence versus Randomized Controlled Trial: Clinical Research Based on Electronic Medical Records.真实世界证据与随机对照试验:基于电子病历的临床研究。
J Korean Med Sci. 2018 Jun 26;33(34):e213. doi: 10.3346/jkms.2018.33.e213. eCollection 2018 Aug 20.
2
Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness.用于评估药物安全性和有效性的真实世界证据与真实世界数据。
JAMA. 2018 Sep 4;320(9):867-868. doi: 10.1001/jama.2018.10136.
3
Clinical experiences and case review of angiotensin II receptor blocker-related angioedema in Korea.韩国血管紧张素 II 受体阻滞剂相关血管性水肿的临床经验和病例回顾。
Basic Clin Pharmacol Toxicol. 2019 Jan;124(1):115-122. doi: 10.1111/bcpt.13097. Epub 2018 Aug 20.
4
Real world evidence: experience and lessons from China.真实世界证据:来自中国的经验与教训。
BMJ. 2018 Feb 5;360:j5262. doi: 10.1136/bmj.j5262.
5
Promises and pitfalls of electronic health record analysis.电子健康记录分析的承诺与陷阱。
Diabetologia. 2018 Jun;61(6):1241-1248. doi: 10.1007/s00125-017-4518-6. Epub 2017 Dec 15.
6
What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder Interviews.什么是真实世界数据?基于文献和利益相关者访谈的定义综述。
Value Health. 2017 Jul-Aug;20(7):858-865. doi: 10.1016/j.jval.2017.03.008. Epub 2017 May 11.
7
Development of Clinical Data Mart of HMG-CoA Reductase Inhibitor for Varied Clinical Research.用于各类临床研究的HMG-CoA还原酶抑制剂临床数据集市的开发。
Endocrinol Metab (Seoul). 2017 Mar;32(1):90-98. doi: 10.3803/EnM.2017.32.1.90. Epub 2017 Feb 28.
8
Use of Moderate-Intensity Statins for Low-Density Lipoprotein Cholesterol Level above 190 mg/dL at Baseline in Koreans.韩国人基线低密度脂蛋白胆固醇水平高于190mg/dL时使用中等强度他汀类药物的情况。
Basic Clin Pharmacol Toxicol. 2017 Oct;121(4):272-278. doi: 10.1111/bcpt.12765. Epub 2017 Jul 9.
9
Real-World Evidence - What Is It and What Can It Tell Us?真实世界证据——它是什么以及能告诉我们什么?
N Engl J Med. 2016 Dec 8;375(23):2293-2297. doi: 10.1056/NEJMsb1609216.
10
Statin-related aminotransferase elevation according to baseline aminotransferases level in real practice in Korea.韩国实际临床中他汀类药物相关转氨酶升高与基线转氨酶水平的关系
J Clin Pharm Ther. 2016 Jun;41(3):266-72. doi: 10.1111/jcpt.12377. Epub 2016 Mar 25.